Houston, TX · Founded 2014 · Privately Held (backing)
Developer of a drug discovery platform designed to help pharma clients expand their drug discovery pipeline. Resonant Therapeutics is based in Houston, TX and was founded in 2014. It is valued at about $17.3 million as of Oct 2026, set by institutional fund marks. It has raised $6.1 million across 1 recorded round; the latest was a $2.5 million seed round in Oct 2021.
PMV mark · valuation
$17.3M
Oct 2026
Priced at
its later-stage round
Oct 2021
Total raised
$6.1M
Last round
Seed Round
Oct 2021
Cap table — not yet on record
Resonant Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Where does Resonant Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Resonant Therapeutics's 1 recorded funding rounds.
